2020-11-17 10:13:04 GDRX GoodRx
Amazon.com
11/17/20 11/1710:13 11/17/2010:13 | GoodRx falls after Amazon launches new pharmacy offeringsAfter Amazon.com (AMZN) announced two new pharmacy offerings - Amazon Pharmacy, a new store on Amazon, and an Amazon Prime prescription savings benefit - shares of several large publicly-traded retail pharmacy chain owners are sliding. In early morning trading, shares of CVS Health (CVS) are down 7%, shares of Walgreens Boots Alliance (WBA) are down 8% and shares of Rite Aid (RAD) are down 14%. Meanwhile, shares of GoodRx (GDRX), which operates the largest healthcare-focused internet platform that provides users access to prescription drug discounts nationwide, are down 14% to $40.38 in morning trading following Amazon's announcements. GoodRx
Amazon.com
CVS Health
Walgreens Boots Alliance
Rite Aid
|
|
---|---|---|
|
General news
| FX Action: USD-JPY has… Story temporarily locked. |
General news
| FX Action: The Canadian… Story temporarily locked. |
General news
| FX Update: The dollar has… Story temporarily locked. |
General news
| Asian Market Update:… Asian Market Update: Treasury yields have stabilised after selling off yesterday after Fed Chairman Powell failed to push back against the rise in rate. the U.S. 10-year rate corrected slightly overnight but remains at 1.56%. JGBs, meanwhile rallied after BoJ's Kuroda squashed speculation that the central bank would widen the implicit band around the yield curve target. The 10-year rate is currently down -5.3 bp at 0.079%, while yields jumped 6.0 bp and 7.5 bp in Australia and New Zealand. Stock markets across Asia traded mixed, with indices moving up from early lows. Nikkei and ASX were still down -0.2% and -0.7% respectively at the close, but Hang Seng and CSI 300 are currently posting fractional gains. Oil prices jumped higher after the OPEC+ meeting decided to maintain current output levels. The front end WTI future is currently trading at USD 64.60 per barrel. In FX markets meanwhile the dollar was supported, while the yen struggled, leaving USD-JPY at 108.24. |
General news
| U.S. trade preview: the… Story temporarily locked. |
General news
| U.S. nonfarm payroll… U.S. nonfarm payroll preview: analysts expect a 350k increase in February nonfarm payrolls after the 49k increase in January, and following the -227k decline in December. Analysts assume a 25k factory jobs increase in February, after a -10k January drop. Analysts assume the jobless rate will sustain the January plunge to 6.3% from 6.7% in December. Hours-worked are assumed to be flat after a 0.9% January bounce, with the workweek slipping to 34.9 from 35.0 in January. Average hourly earnings are assumed to rise just 0.1% in February, as analysts further unwind the December distortion that left a 1.0% earnings surge with a big drop in low-wage workers. The y/y wage gain should slip to 5.2% from 5.4%. Analysts previously saw a 3.5% expansion-high pace for y/y wage gains in both February and July of 2019, before the pandemic-boost to an 8.0% April peak. Analysts expect the payroll rebound to gain steam in 2021 following the winter lull, thanks to stimulus deposits and vaccines. |
General news
| BoJ's Kuroda sees no… Story temporarily locked. |
Upgrade
|
Paycom upgraded to Buy from Hold at Jefferies »
21:28 03/04/21 03/0421:28 03/04/2121:28
PAYC
Paycom
Jefferies analyst Samad… Jefferies analyst Samad Samana upgraded Paycom Software to Buy from Hold with a $470 price target. The analyst cites valuation for the upgrade following the recent selloff. The stock is off 25% from all-time highs and 23% year-to-date, with the valuation now below the pre-pandemic peak, Samana tells investors in a research note. Fundamentally, Paycom is well positioned to return to greater than 20% growth in 2021 and sustain acceleration into 2022 on "strong" new bookings, says Samana. Further, employment tailwinds "would be an extra boost," says the analyst. ShowHide Related Items >><<
|
Recommendations
|
NextCure price target lowered to $26 from $32 at Piper Sandler »
20:39 03/04/21 03/0420:39 03/04/2120:39
NXTC
NextCure
Piper Sandler analyst… Piper Sandler analyst Edward Tenthoff lowered the firm's price target on NextCure to $26 from $32 and keeps an Overweight rating on the shares after its FY20 results. The analyst notes that his updated price target reflect the company's pipeline value realignment and a reduction in projected enterprise value of $527M, down from $663M, though its NC318 S15+ and NC410 data readouts remain on track for Q4 of this year. ShowHide Related Items >><<
|
Earnings
|
NextCure reports FY20 EPS ($1.33), consensus ($1.34) »
20:35 03/04/21 03/0420:35 03/04/2120:35
NXTC
NextCure
Cash, cash equivalents,… Cash, cash equivalents, and marketable securities, excluding restricted cash as of December 31, 2020, were $283.4 million as compared with $334.6 million as of December 31, 2019. The company states: "Based on its current research and development plans, NextCure expects its existing cash, cash equivalents and marketable securities will enable it to fund operating expenses and capital expenditure requirements into the second half of 2023." ShowHide Related Items >><<
|
Syndicate
|
Nurix Therapeutics 4.5M share Secondary priced at $31.00 »
20:03 03/04/21 03/0420:03 03/04/2120:03
NRIX
Nurix Therapeutics
The deal size was… The deal size was increased to 4.5M shares from 4.0M and priced below the last closing price of $32.49. JPMorgan, Piper Sandler and Stifel are acting as joint book running managers for the offering. ShowHide Related Items >><<
|
Hot Stocks
|
ShotSpotter CFO buys 7.5K shares of common stock »
19:52 03/04/21 03/0419:52 03/04/2119:52
SSTI
ShotSpotter
In a regulatory filing,… In a regulatory filing, ShotSpotter disclosed that its CFO Alan Stewart bought 7.5K shares of common stock on March 3rd in a total transaction size of $285K. ShowHide Related Items >><<
|
Syndicate
|
Sun Communities 7M share Secondary priced at $140.00 »
19:11 03/04/21 03/0419:11 03/04/2119:11
SUI
Sun Communities
The deal priced below the… The deal priced below the last closing price of $141.80. Citi, BofA, BMO Capital, JPMorgan and RBC Capital are acting as joint book running managers for the offering. ShowHide Related Items >><<
|
On The Fly
|
Fly Intel: After-Hours Movers »
19:09 03/04/21 03/0419:09 03/04/2119:09
PLYA
Playa Hotels & Resorts
Manchester United
Gap
Quanex
Cooper Companies
Alphatec
Smith & Wesson Brands
Imax
Jamf Holding
Waitr Holdings
Ocular Therapeutix
Western Digital
Evofem
Medallia
DermTech
Opendoor Technologies
SmileDirectClub
Guidewire
Costco
Broadcom
Slack Technologies
Check out this evening's… ShowHide Related Items >><<
|
Upgrade
|
Michaels upgraded to Equal Weight from Underweight at Morgan Stanley »
19:04 03/04/21 03/0419:04 03/04/2119:04
MIK
Michaels
Morgan Stanley analyst… Morgan Stanley analyst Simeon Gutman upgraded Michaels to Equal Weight from Underweight with a $22 price target. ShowHide Related Items >><<
|
Downgrade
|
Five Prime downgraded to Hold from Buy at Jefferies »
19:03 03/04/21 03/0419:03 03/04/2119:03
FPRX
Five Prime
Jefferies analyst Eun… Jefferies analyst Eun Yang downgraded Five Prime to Hold from Buy with a $38 price target. ShowHide Related Items >><<
|
Hot Stocks
|
Square director sells 8.2K shares of common stock »
18:42 03/04/21 03/0418:42 03/04/2118:42
SQ
Square
In a regulatory filing,… In a regulatory filing, Square disclosed that its director Mary Meeker sold 8.2K shares of common stock on March 2nd in a total transaction size of $2.07M, reducing her holding by 2%. ShowHide Related Items >><<
|
Hot Stocks
|
TriMas' Parker sells over 21,000 common shares »
18:41 03/04/21 03/0418:41 03/04/2118:41
TRS
TriMas
In a regulatory filing,… In a regulatory filing, TriMas director Herbert K. Parker disclosed the sale of 21,158 common shares of the company on March 2 at a price of $32.16 per share. ShowHide Related Items >><<
|
Recommendations
|
Micron price target raised to $118 from $102 at Goldman Sachs »
18:39 03/04/21 03/0418:39 03/04/2118:39
MU
Micron
Goldman Sachs analyst… Goldman Sachs analyst Toshiya Hari raised the firm's price target on Micron to $118 from $102 and keeps a Buy rating on the shares. Hari said that, based on his recent industry checks, he believes DRAM supply/demand dynamics have improved since his last earnings update. The analyst said that while feedback on enterprise demand remains muted or mixed, quantitative and anecdotal data points on essentially every other key end-market have continued to be robust or have strengthened. Hari also said that feedback on NAND supply/demand from industry discussions were "universally positive." ShowHide Related Items >><<
|
Hot Stocks
|
PDC Energy's Crisafio sells 17,000 common shares »
18:33 03/04/21 03/0418:33 03/04/2118:33
PDCE
PDC Energy
In a regulatory filing,… In a regulatory filing, PDC Energy director Anthony J. Crisafio disclosed the sale of 17,000 common shares of the company on March 3 at a price of $36.30 per share. ShowHide Related Items >><<
|
Hot Stocks
|
SPDR Gold Shares holdings fall from 1,082.38MT to 1,078.30MT »
18:30 03/04/21 03/0418:30 03/04/2118:30
GLD
SPDR Gold Shares
This is the lowest level… This is the lowest level of holdings since May 7th, 2020. ShowHide Related Items >><<
|
Periodicals
|
Wells Fargo to give all employees PTO for vaccine appointments, Reuters says »
18:26 03/04/21 03/0418:26 03/04/2118:26
WFC
Wells Fargo
Wells Fargo intends to… Wells Fargo intends to give all employees up to eight hours of paid time off to accommodate coronavirus vaccine appointments, Reuters' Imani Moise reports, citing a memo. "While we understand that choosing to be vaccinated is a personal decision, we encourage you to consider getting the vaccine when it's available to you," head of human resources David Galloreese told all staff in a memo. Reference Link ShowHide Related Items >><<
|
Hot Stocks
|
Splunk CEO: We're growing our cloud business like no tomorrow »
18:25 03/04/21 03/0418:25 03/04/2118:25
SPLK
Splunk
In an interview on… In an interview on CNBC's Mad Money, Doug Merritt said, "It's a tale of two businesses for Splunk." The company is growing cloud revenue very quickly he noted. Merritt said Splunk corrected in Q4 and changed a lot of its methodologies. "We're making long term investments for the health of our customers," he added. ShowHide Related Items >><<
|
Upgrade
|
Western Digital upgraded to Buy from Neutral at Goldman Sachs »
18:10 03/04/21 03/0418:10 03/04/2118:10
WDC
Western Digital
Goldman Sachs analyst… Goldman Sachs analyst Toshiya Hari upgraded Western Digital to Buy from Neutral with a price target of $85, up from $56. The analyst is citing his increased assumptions for DRAM and NAND memory pricing after the recent industry checks suggest improved demand environment and "continued" supply-side discipline. Hari adds that he is positive on Western Digital's improved NAND cost execution, and also believes that the company is positioned to regain market share that was lost in 2020. ShowHide Related Items >><<
|
Downgrade
|
Skyworks downgraded to Neutral from Buy at Goldman Sachs »
18:04 03/04/21 03/0418:04 03/04/2118:04
SWKS
Skyworks
Goldman Sachs analyst… Goldman Sachs analyst Toshiya Hari downgraded Skyworks to Neutral from Buy with a $135 price target. Hari downgraded the stock given limited upside potential to his unchanged price target. The analyst added that while he remains constructive on the company's long-term competitive position in the growing radio frequency market, he anticipates that the stock will perform largely in line with his broader semiconductor and semiconductor capital equipment coverage universe through the balance of the year. ShowHide Related Items >><<
|